Article Text

PDF
THU0046 Prevalence of vitamin D deficiency in rheumatoid arthritis patients: Association with anaemia of inflammation and effect of vitamin D supplementation
  1. A. Abou-Raya1,
  2. S. Abou-Raya1,
  3. M. Helmii2
  1. 1Rheumatology, Faculty of Medicine, University of Alexandria & Alexandria Centre for Women’s Health
  2. 2Biochemistry, Medical Research Institute, Alexandria, Egypt

Abstract

Background Anaemia of inflammation (AI) and vitamin D deficiency can both contribute to significant morbidity in rheumatoid arthritis (RA) patients. The potential relationship between them remains poorly understood. A common feature of RA associated with AI is immune activation and production of inflammatory cytokines. In AI, proinflammatory cytokines affect iron metabolism. Vitamin D is recognized as having potent immunomodulatory properties that has prompted its potential use in autoimmune diseases including RA.

Objectives To determine the prevalence of 25 hydroxyvitamin D deficiency in RA patients with AI and to assess the association between 25 hydroxyvitamin D and AI and the efficacy of vitamin D supplementation.

Methods Eighty-five patients all fulfilling the ACR criteria for RA were enrolled in this 16-week randomized placebo-controlled study. Inclusion criteria included premenopausal women and men of the same body mass index and ethnicity having AI, that is, low circulating iron <60μ/dl and no evidence of iron deficiency anaemia Tfr/log ferritin <15. Vitamin D deficiency was defined as serum levels <30ng/ml. Fifty-five healthy age-sex-BMI and ethnically matched controls were also recruited. Patients were randomized in a 1:1 ratio to receive either oral cholecalciferol 2000IU/day or placebo for 4 months together with standard RA treatment. Outcome measures included improvement of AI, inflammatory markers before and after vitamin D supplementation. Vitamin D levels were measured by Liaison immunoassay (normal 30-100ng/ml). Serum levels of proinflammatory cytokines IL-6 and TNF-alpha and acute phase reactants: hsCRP, ESR and fibrinogen and blood indices were measured at baseline and after vitamin D supplementation.

Results The prevalence of vitamin D deficiency was 54% in RA patients with AI compared to 12% in the healthy controls, p=0.006. There was a significant positive correlation between vitamin D deficiency and AI, r =0.537; p=0.003. Following vitamin D supplementation a statistically significant improvement in the indices of AI occurred. Inflammatory markers and proinflammatory cytokines decreased significantly after vitamin D supplementation.

Conclusions Vitamin D may attenuate inflammation and further studies to confirm whether vitamin D supplementation improves AI are needed.

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.